Agios Pharmaceuticals (AGIO) EBT Margin Growth (3y) (2015 - 2026)
Agios Pharmaceuticals (AGIO) EBT Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | 83,960.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83,960.00 |
| Dec 31, 2025 | 170,693.00 |
| Sep 30, 2025 | 180,480.00 |
| Jun 30, 2025 | 73,660.00 |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2023 | -115,875.00 |
| Sep 30, 2023 | -100,614.00 |
| Jun 30, 2023 | -112,252.00 |
| Mar 31, 2023 | -145,528.00 |
| Dec 31, 2022 | -195,218.00 |
| Sep 30, 2022 | -219,141.00 |
| Jun 30, 2022 | -136,493.00 |
| Mar 31, 2022 | -1.22 Mn |
| Dec 31, 2020 | 378,994.00 |
| Sep 30, 2020 | 45,563.00 |
| Dec 31, 2019 | 86,930.00 |
| Sep 30, 2019 | 150,838.00 |
| Jun 30, 2019 | 142,207.00 |
| Mar 31, 2019 | -1,219.00 |
| Dec 31, 2018 | -107,329.00 |